Skip to main content
. 2013 Feb 27;56(11):1667–1674. doi: 10.1093/cid/cit125

Table 1.

Characteristics of Conventional Genotypic, Phenotypic, and Ultrasensitive Drug Resistance Assays

Assay Advantages Disadvantages Currently in Clinical Use
Conventional genotypic (Sanger DNA sequencing)
  • Relatively inexpensive

  • Rapid turnaround

  • Difficult to interpret complex resistance patterns

  • Misses minority variants

Yes
Phenotypic
  • Avoids need to interpret complex mutational patterns

  • Intuitive results

  • Expensive

  • Slow turnaround time

  • Limited availability outside Europe or United States and Canada

  • Less sensitive than standard genotype testing

Yes
Ultrasensitive techniques
 Allele-specific polymerase chain reaction
  • Highly sensitivea

  • Detects only a few targeted resistance mutations

No
 Deep sequencingb
  • Moderately to highly sensitivea

  • Evaluates entire region of interest.

  • Cost

  • Need for computational support

Yesc
 Oligonucleotide ligation assay
  • Moderately sensitivea

  • Avoids expensive equipment or specialized technical expertise

  • Only detects a few targeted resistance mutations

  • Assay is not quantitative

No

Adapted from [104].

a Test sensitivity and limits of detection vary by testing site and patient-specific variables (eg, viral load, sample volume).

b Refers to the Roche/454, Illumina, and other next-generation sequencing platforms.

c The Roche/454 deep-sequencing system is currently used as part of a coreceptor tropism test developed by Quest Diagnostics (Madison, New Jersey).